UCB's Global Corporate Website
Welcome to UCB in the United States

Jun

12

UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024

Jun

10

Nicole Watson: Mom, Caregiver, and Best Friend, Shares How Her Daughter Emma, Diagnosed with Dravet Syndrome, Embraces Each Day with Love

May

31

Go Behind The Mystery of Myasthenia Gravis On Myasthenia Gravis Awareness Month

May

31

Empowering the Hidradenitis Suppurativa Community: UCB's Triple Approach

May

23

UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa

May

10

Moms Really Can Do It All - Meet Tracy: a Mom, Caregiver, Neuroscientist, and Advocate in the Rare Disease Community

May

06

Evolving Expectations for Arthritis Management

Apr

12

UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting

Apr

11

Our Leadership and Legacy in Epilepsy and Rare Syndromes

Apr

10

Striving to Make HStory: UCB’s Mission to Raise Awareness for Hidradenitis Suppurativa